These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Binding of maytansine to tubulin: competition with other mitotic inhibitors. Lin CM, Hamel E, Wolpert-DeFilippes MK. Res Commun Chem Pathol Pharmacol; 1981 Mar 12; 31(3):443-51. PubMed ID: 7255878 [Abstract] [Full Text] [Related]
29. Free energy calculations on the binding of colchicine and its derivatives with the alpha/beta-tubulin isoforms. Mane JY, Klobukowski M, Huzil JT, Tuszynski J. J Chem Inf Model; 2008 Sep 12; 48(9):1824-32. PubMed ID: 18712858 [Abstract] [Full Text] [Related]
31. [4-(imidazol-1-yl)thiazol-2-yl]phenylamines. A novel class of highly potent colchicine site binding tubulin inhibitors: synthesis and cytotoxic activity on selected human cancer cell lines. Mahboobi S, Sellmer A, Höcher H, Eichhorn E, Bär T, Schmidt M, Maier T, Stadlwieser JF, Beckers TL. J Med Chem; 2006 Sep 21; 49(19):5769-76. PubMed ID: 16970401 [Abstract] [Full Text] [Related]